Kyle A Blum
Overview
Explore the profile of Kyle A Blum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Malouf G, Flippot R, Dong Y, DiNatale R, Chen Y, Su X, et al.
Sci Rep
. 2020 Jan;
10(1):701.
PMID: 31959902
Sarcomatoid clear-cell renal cell carcinomas (sRCC) are associated with dismal prognosis. Genomic alterations associated with sarcomatoid dedifferentiation are poorly characterized. We sought to define the genomic landscape of sRCC and...
22.
Auffenberg G, Curry M, Gennarelli R, Blum K, Elkin E, Russo P
J Urol
. 2020 Jan;
203(6):1094-1100.
PMID: 31913076
Purpose: With anecdotal observations of atypical recurrences following minimally invasive surgery and alongside new concerns following cervical cancer surgery, there is a need to evaluate cancer specific outcomes for minimally...
23.
DiNatale R, Gorelick A, Makarov V, Blum K, Silagy A, Freeman B, et al.
Eur Urol Focus
. 2019 Dec;
7(2):381-389.
PMID: 31813809
Background: TCEB1-mutant renal cell carcinoma (RCC) is a rare variant of RCC with clear-cell features. Owing to its unique morphological and molecular features it has recently been proposed as a...
24.
DiNatale R, Xie W, Becerra M, Silagy A, Attalla K, Sanchez A, et al.
Eur Urol Oncol
. 2019 Nov;
3(1):47-56.
PMID: 31735646
Background: One of the main challenges in the management of renal cell carcinoma (RCC) is risk-stratifying patients who present with metastatic disease. Tumor size is an important predictor of survival...
25.
Silagy A, Mano R, Blum K, DiNatale R, Marcon J, Tickoo S, et al.
Urology
. 2019 Nov;
136:169-175.
PMID: 31726184
Objective: To assess which patients respond best following cytoreductive nephrectomy for renal cell carcinoma (RCC) with sarcomatoid dedifferentiation (sRCC) and whether outcomes are improving over time. Methods: We identified 562...
26.
Mano R, Flynn J, Blum K, Silagy A, DiNatale R, Marcon J, et al.
Urol Oncol
. 2019 Oct;
37(12):916-923.
PMID: 31590969
Objective: Preoperative inflammatory parameters are associated with outcome in renal cell carcinoma; however, their predictive value in tumors with sarcomatoid dedifferentiation (sRCC) is uncertain. We aimed to evaluate the association...
27.
Silagy A, Flynn J, Mano R, Blum K, Marcon J, DiNatale R, et al.
Urol Oncol
. 2019 Sep;
37(11):811.e9-811.e16.
PMID: 31521530
Objectives: To report the overall survival (OS) outcomes of patients with nonclear cell renal cell carcinoma (nccRCC) treated at our institution with a cytoreductive nephrectomy (CN) and better understand the...
28.
Gatto F, Blum K, Hosseini S, Ghanaat M, Kashan M, Maccari F, et al.
Eur Urol Oncol
. 2019 Jun;
1(5):364-377.
PMID: 31158075
Background: Plasma glycosaminoglycan (GAG) measurements, when aggregated into diagnostic scores, accurately distinguish metastatic clear-cell renal cell carcinoma (RCC) from healthy samples and correlate with prognosis. However, it is unknown if...
29.
Bamberger J, Blum K, Kan K, Parkhomenko E, Gallante B, Gupta M
J Endourol
. 2019 Jun;
33(9):755-760.
PMID: 31154910
Calcium oxalate (CaOx) is the predominate component within renal calculi and can be divided into two subtypes: CaOx-monohydrate (COM) and CaOx-dihydrate (COD). COM and COD form in differing urinary environments,...
30.
Tran T, Bamberger J, Blum K, Parkhomenko E, Thai J, Chandhoke R, et al.
Urology
. 2019 Apr;
130:43-47.
PMID: 31029671
Objective: To evaluate whether preoperative computed tomography (CT) findings could predict the presence of an impacted stone. Preoperative identification of an impacted ureteral stone may influence patient preparation and operative...